Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
38,890
-16,649
-30% -$811K 0.01% 573
2026
Q1
$2.38M Buy
55,539
+6,743
+14% +$290K 0.02% 535
2025
Q4
$2.14M Sell
48,796
-4,352
-8% -$180K 0.02% 527
2025
Q3
$2.2M Sell
53,148
-3,480
-6% -$140K 0.02% 525
2025
Q2
$2.5M Sell
56,628
-2,782
-5% -$111K 0.02% 490
2025
Q1
$2.19M Sell
59,410
-1,961
-3% -$69.9K 0.02% 503
2024
Q4
$2.04M Buy
61,371
+126
+0.2% +$4.09K 0.02% 517
2024
Q3
$1.59M Buy
61,245
+1,761
+3% +$43.8K 0.02% 575
2024
Q2
$1.34M Sell
59,484
-3,269
-5% -$72.5K 0.01% 599
2024
Q1
$1.49M Sell
62,753
-2,565
-4% -$57K 0.02% 605
2023
Q4
$1.57M Sell
65,318
-3,454
-5% -$75.1K 0.02% 537
2023
Q3
$1.5M Sell
68,772
-964
-1% -$20.2K 0.02% 537
2023
Q2
$1.33M Sell
69,736
-1,408
-2% -$27.1K 0.02% 574
2023
Q1
$1.38M Buy
71,144
+522
+0.7% +$9.09K 0.02% 554
2022
Q4
$1.13M Buy
70,622
+6,010
+9% +$98K 0.02% 591
2022
Q3
$1.01M Sell
64,612
-483
-0.7% -$9.33K 0.02% 576
2022
Q2
$1.35M Buy
65,095
+3,638
+6% +$75K 0.03% 485
2022
Q1
$1.39M Sell
61,457
-1,053
-2% -$20.6K 0.02% 482
2021
Q4
$1.14M Buy
62,510
+359
+0.6% +$6.87K 0.02% 555
2021
Q3
$1.31M Sell
62,151
-1,228
-2% -$22.8K 0.03% 458
2021
Q2
$1.16M Buy
63,379
+19,229
+44% +$448K 0.02% 526
2021
Q1
$997K Buy
44,150
+129
+0.3% +$2.91K 0.02% 478
2020
Q4
$884K Buy
44,021
+304
+0.7% +$6.36K 0.02% 501
2020
Q3
$1.07M Buy
43,717
+4,884
+13% +$114K 0.03% 398
2020
Q2
$922K Buy
+38,833
New +$900K 0.02% 402

Other funds holding EXEL

Xponance's EXEL Position: Q2 2026 in Review

Xponance reduced its Exelixis (EXEL) stake by 30% in Q2 2026, selling an estimated $811K and leaving 38,890 shares worth $2.12M. The position accounts for 0.01% of the portfolio, ranked #573.

Xponance first reported a position in EXEL in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.5M in Q2 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Xponance held 38,890 shares of Exelixis worth $2.12M as of Q2 2026.
  • Xponance sold 16,649 Exelixis shares in Q2 2026, an estimated $811K.
  • Exelixis made up 0.01% of Xponance's portfolio in Q2 2026, its #573 holding.
  • Xponance first reported a position in Exelixis in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Exelixis position peaked at $2.5M in Q2 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.